Guideline Updates Resource Center

Deborah Stephens, DO, University of Utah

Videos

Overview of the Updated NCCN Guidelines on Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

05/17/2023

Deborah Stephens, DO, Huntsman Cancer Institute, University of Utah, and member of the NCCN Guidelines Panel for the Management of CLL, provides an overview of the latest updates to the NCCN Clinical Practice Guidelines in Oncology (NCCN...

Deborah Stephens, DO, Huntsman...

05/17/2023

Journal of Clinical Pathways

Guideline Updates

NCCN Updates Clinical Practice Guidelines for Multiple Myeloma

01/11/2023

Yvette C. Terrie

The NCCN recently published updated recommendations for the management of MM regarding newly diagnosed transplant-eligible and transplant-ineligible patients with MM, maintenance, and previously treated MM, and principles of management of...

The NCCN recently published...

01/11/2023

Journal of Clinical Pathways

Guideline Updates

NCCN Updates Clinical Practice Guidelines in Thyroid Carcinoma

09/08/2022

Yvette C Terrie

The National Comprehensive Cancer Network recently published updated recommendations regarding management of medullary thyroid carcinoma and anaplastic thyroid carcinoma, along with surgical management of differentiated thyroid carcinoma.

The National Comprehensive...

09/08/2022

Journal of Clinical Pathways

Guideline Updates

NCCN Updates Therapy Guidelines in Bladder Cancer

08/26/2022

Yvette C Terrie

NCCN Guidelines Panel for Bladder Cancer presented data evaluating new treatment options in bladder cancer, as well as relevant updates to the NCCN Clinical Practice Guidelines in Oncology for Bladder Cancer.

NCCN Guidelines Panel for...

08/26/2022

Journal of Clinical Pathways

Updated NCCN Guidelines on B-Cell Lymphomas

Sponsored

JCP Special Report

Overview of the Updated NCCN Guidelines on B-Cell Lymphomas

06/15/2022

Robert Fee

Updated multiple times in 2022, the National Comprehensive Cancer Network (NCCN) Guidelines for B-Cell Lymphomas provide recommendations for the prevention, diagnosis, and management of malignancies.

Updated multiple times in 2022,...

06/15/2022

Journal of Clinical Pathways

Guideline Updates

NCCN Updates Clinical Practice Guideline for Small Cell Lung Cancer

03/24/2021

Janelle Bradley

NCCN released an update to its clinical practice guideline for small cell lung cancer, featuring modifications for supportive care and subsequent systemic therapy.

NCCN released an update to its...

03/24/2021

Journal of Clinical Pathways

NCCN Updates Clinical Practice Guideline for Kidney Cancer

03/24/2021

Janelle Bradley

On March 23, 2021, the National Comprehensive Cancer Network (NCCN) released an update to its clinical practice guideline for kidney cancer.

On March 23, 2021, the National...

03/24/2021

Journal of Clinical Pathways

Guideline Updates

NCCN Updates Clinical Practice Guideline for Central Nervous System Cancers

03/24/2021

Janelle Bradley

NCCN released an update to its clinical practice guideline for central nervous system cancers, adding lorlatinib as a category 2A recommendation for brain metastases from NSCLC.

NCCN released an update to its...

03/24/2021

Journal of Clinical Pathways

Guideline Updates

NCCN Updates Clinical Practice Guideline for Bladder Cancer

03/24/2021

Janelle Bradley

NCCN updated its clinical practice guideline for bladder cancer, removing atezolizumab as an alternative second-line systemic therapy option for locally advanced or metastatic disease.

NCCN updated its clinical...

03/24/2021

Journal of Clinical Pathways

NCCN Updates Clinical Practice Guideline for B-Cell Lymphomas

03/17/2021

Janelle Bradley

The National Comprehensive Cancer Network update of these guidelines covers follicular lymphoma.

The National Comprehensive...

03/17/2021

Journal of Clinical Pathways

Current Issue

April 2024

Volume 10

Issue 2

Current Issue

Issue Archive

Special Reports

Sponsored

JCP Special Report

Overview of the Updated NCCN Guidelines on B-Cell Lymphomas

06/15/2022

Robert Fee

Updated multiple times in 2022, the National Comprehensive Cancer Network (NCCN) Guidelines for B-Cell Lymphomas provide recommendations for the prevention, diagnosis, and management of malignancies.

Updated multiple times in 2022,...

06/15/2022

Journal of Clinical Pathways

Sponsored

JCP Special Report

Biliary Tract Cancers (BTCs) Unveiled: Expert Perspectives on Unique Challenges and Management Considerations

11/20/2023

In this supplement, learn about the complexities of biliary tract cancer (BTC) with insights from a distinguished expert panel. The supplement examines the patient journey to diagnosis and treatment of BTCs, evaluates the impact of the...

In this supplement, learn about...

11/20/2023

Journal of Clinical Pathways

Sponsored

Special Report

Shedding Light on Non-Small Cell Lung Cancer & Its Impact on Patients

04/03/2023

This supplement aims to raise awareness about non-small cell lung cancer (NSCLC) and its impact on patients by providing comprehensive information to help improve early detection and appropriate care.

This supplement aims to raise...

04/03/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

Brukinsa® (Zanubrutinib) for Chronic Lymphocytic Leukemia

03/31/2023

In this product monograph, read an interview with Jeff P. Sharman, MD, as he discusses important BRUKINSA® trial data including efficacy, safety, dosing, administration, and other relevant data. These key findings supported the Food and Drug...

In this product monograph, read...

03/31/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

Tumor Lysis Syndrome: Early Diagnosis and Management

01/04/2023

This review summarizes the diagnosis, pathophysiology, and evidence-based guidelines for the prevention and management of tumor lysis syndrome, a common, acute, life-threatening disease primarily in patients with hematologic cancers and solid...

This review summarizes the...

01/04/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

A Tumor Lysis Syndrome Risk Assessment and Its Impact on Patients

08/09/2022

In an interview with Journal of Clinical Pathways, Nicholas Short, MD, shares objectives on the design and benefits of MD Anderson’s Tumor Lysis Syndrome clinical assessment for patient risk and impact on patient care.

In an interview with Journal of...

08/09/2022

Journal of Clinical Pathways

Sponsored

JCP Special Report

Overview of the Updated NCCN Guidelines on B-Cell Lymphomas

06/15/2022

Robert Fee

Updated multiple times in 2022, the National Comprehensive Cancer Network (NCCN) Guidelines for B-Cell Lymphomas provide recommendations for the prevention, diagnosis, and management of malignancies.

Updated multiple times in 2022,...

06/15/2022

Journal of Clinical Pathways

Sponsored

Special Report

Expanded Indication for Zanubrutinib: Marginal Zone Lymphoma and Waldenström’s Macroglobulinemia

06/10/2022

In an interview with Journal of Clinical Pathways, Mitul Gandhi, MD, reviews the clinical impact and treatment approaches and challenges for patients with marginal zone lymphoma and Waldenström’s macroglobulinemia.

In an interview with Journal of...

06/10/2022

Journal of Clinical Pathways

JCP Special Report

Recommendations for Creating an Oncology Clinical Pathways Framework Tool Based on Payer, Provider, and Patient Priorities: Findings From the 2021 Care Pathways Working Group

05/20/2022

Winston Wong, PharmD

Gordon Kuntz

Robin T Zon, MD, FACP, FASCO

2021 Care Pathways Working Group

The Journal of Clinical Pathways convened the 2021 Care Pathways Working Group to identify and reconcile the different pathway drivers for each stakeholder now and five years into the future, creating a framework tool based on oncology care...

The Journal of Clinical Pathways...

05/20/2022

Journal of Clinical Pathways

Overview of the Updated NCCN Guidelines on Triple-Negative Breast Cancer

Sponsored

Special Report

Overview of the Updated NCCN Guidelines on Triple-Negative Breast Cancer

12/15/2021

Deborah Abrams Kaplan

NCCN released updates to its practice guidelines on treating triple-negative breast cancer, featuring updates on sacituzumab govitecan recommendations and more.

NCCN released updates to its...

12/15/2021

Journal of Clinical Pathways

Sponsored

Special Report

Navigating the Patient Journey for Unresectable Stage III Non-Small Cell Lung Cancer

09/16/2021

.ryan-test { display: none; } .body-content h3 { font-size: 18px; line-height: 18px; color: #000000; font-weight: 600px; } .related-content { display: none; } .body-content div > div:nth-of-type(3) .paragraph > h3 >...

.ryan-test { display:...

09/16/2021

Journal of Clinical Pathways

Journal of Clinical Pathways Newsletter

Guideline Updates Resource Center

Current Issue

Special Reports

Subscribe

Twitter

Specialties

Events

Year Round Education

HMP Global Products